Histopathologic diagnosis | Management | Row total | |||||
---|---|---|---|---|---|---|---|
No treatment indicated (row%) (column%) | Immediate management based on colposcopic impression (row%) (column%) | Delayed excisional treatment on a recall visit (row%) (column%) | |||||
With ablation | With LLETZ | Completed | Pendinga | ||||
<CIN2 | 1158 (88.7%) (100.0%) | 90 (6.9%) (78.9%) | 54 (4.1%) (69.2%) | 3c (0.2%) (12.0%) | 0 | 1305 (100%) | |
CIN2 | Diagnosed on biopsy/LLETZ | 0 | 10 (40.0%) (8.8%) | 11 (44.0%) (14.1%) | 2 (8.0%) (8.0%) | 2 (8.0%) (16.7%) | 25 (100%) |
Diagnosed on ECC | 0 | 0 | 0 | 8 (66.7%) (32.0%) | 4 (33.3%) (33.3%) | 12 (100%) | |
CIN3 | Diagnosed on biopsy/LLETZ | 0 | 13 (38.2%) (11.4%) | 12 (35.3%) (15.4%) | 5 (14.7%) (20.0%) | 4 (11.8%) (33.3%) | 34 (100%) |
Diagnosed on ECCb | 0 | 1 (16.7%) (0.9%) | 0 | 3 (50.0%) (12.0%) | 2 (33.3%) (16.7%) | 6 (100%) | |
Cancer | Diagnosed on biopsy/LLETZ | 0 | 0 | 1d (20.0%) (1.3%) | 4 (80.0%) (16.0%) | 0 | 5 (100%) |
Column total | 1158 (100%) | 114 (100%) | 78 (100%) | 25 (100%) | 12 (100%) | Grand total = 1387 |